Streetbeat News

Price Targets

CNMD

Needham analyst Mike Matson has reiterated a 'Buy' rating on Conmed (NYSE:CNMD) and maintained a price target of $139.

Portfolio Pulse from richadhand@benzinga.com

July 24, 2023 | 11:03 am

ABT

Barclays analyst Matt Miksic maintains an Overweight rating on Abbott Laboratories (NYSE:ABT) and raises the price target from $127 to $132.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2023 | 11:02 am

IMVT

Wells Fargo analyst Derek Archila has maintained an Overweight rating on Immunovant (NASDAQ:IMVT) and raised the price target from $27 to $33.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2023 | 11:01 am

ALV

Baird analyst Luke Junk maintains a Neutral rating on Autoliv (NYSE:ALV) and raises the price target from $102 to $106.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2023 | 11:00 am

SHOP

Mizuho analyst Siti Panigrahi maintains a Neutral rating on Shopify (NYSE:SHOP) and raises the price target from $55 to $65.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2023 | 10:58 am

HUBS

Mizuho analyst Siti Panigrahi maintains a Buy rating on HubSpot (NYSE:HUBS) and raises the price target from $480 to $550.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2023 | 10:57 am

PCTY

Mizuho analyst Siti Panigrahi maintains a Neutral rating on Paylocity Holding (NASDAQ:PCTY) and raises the price target from $200 to $225.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2023 | 10:57 am

PAYC

Mizuho analyst Siti Panigrahi maintains a neutral stance on Paycom Software (NYSE:PAYC) and raises the price target from $300 to $350.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2023 | 10:56 am

APP

BTIG analyst Clark Lampen has upgraded AppLovin (NASDAQ:APP) from Neutral to Buy and announced a $34 price target.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2023 | 10:55 am

BILL

Mizuho analyst Siti Panigrahi maintains a Neutral rating on BILL Holdings and raises the price target from $92 to $110.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2023 | 10:53 am